Joseph A. Padilla confessed his culpability in a recent securities fraud case, manipulating Oncology Pharma, Inc. (ONPH) and Charlestowne Premium Beverages Inc. (FPWM) stocks. The U.S. Attorney's Office in the District of Massachusetts is requesting that potential victims of this fraud come forward.

From January to July 2021, Padilla employed manipulative practices with thinly traded ONPH stocks on the over-the-counter (OTC) securities market. These tactics were conceived to falsely inflate the company's stock price. Consequently, Padilla facilitated the sales of roughly three million ONPH shares during a promotional campaign under undisclosed common control, a blatant violation of securities regulations.

In a similar vein, Padilla engaged in an identical scheme from January 2020 to April 2021, involving Charlestowne Premium Beverages Inc. stocks. In this case, he masterminded actions aimed at falsely raising the stock price, fostering the sale of millions of Charlestowne's shares during a promotional campaign.

By December 1, affected individuals who traded either ONPH or FPWM during those timelines are advised to contact the U.S. Attorney's Office and submit any pertinent transaction details. Padilla's sentencing is scheduled for November 1. His accomplice, Kevin C. Dills, pleaded not guilty and is set for trial on February 12, 2024.

As the sentencing of Padilla and the trial of his co-defendant approach, those affected are urged to reach out to the U.S. Attorney's Office.